Discussion paper: Current role of sublingual immunotherapy in allergic diseases;Diskussionspapier: Aktueller stellenwert der sublingualen immuntherapie bei allergischen krankheiten

Allergo Journal

Volumn 13, Issue 7, 2004, Pages 430-434

  Kleine Tebbe, Jörg ^a   Bergmann, Karl Christian ^a   Bufe, Albrecht ^a   Friedrichs, Frank ^a   Fuchs, Thomas ^a   Hirsch, Thomas ^a   Klimek, Ludger ^a   Lepp, Ute ^a   Przybilla, Bernhard ^a   Rakoski, Jürgen ^a   Rebien, Wolfgang ^a   Saloga, Joachim ^a   Schultze Werninghaus, Gerhard ^a   Virchow, Johann Christian ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIRCH POLLEN ALLERGEN; FLUTICASONE; GRASS POLLEN EXTRACT; IMMUNOSUPPRESSIVE AGENT; PLACEBO; POLLEN ANTIGEN; UNCLASSIFIED DRUG;

ALLERGIC DISEASE; ALLERGIC RHINITIS; ASTHMA; BIRCH; DRUG EFFECT; EVALUATION; GRASS POLLEN; IMMUNOTHERAPY; RHINITIS; SHORT SURVEY;

EID: 8344256556     PISSN: 09418849     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03371024     Document Type: Short Survey

References (14)

1. Arzneimittelkommission der deutschen Ärzteschaft. Hyposensibilisierung - Indikationen, Kontraindikationen, unerwünsehte Wirkungen. Dtsch Ärztebl 1997; 94: A330-1
2. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108: S147-334
3. Bufe A, Ziegler-Kirbach E, Stoeckmann E, Heidemann P, Gehlhar K, Holland-Letz T, Braun W. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy 2004; 59: 498-504
4. Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol 2003; 111: 437-48; quiz 449
5. Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, Till SJ, Hamid QA, Nouri-Aria KT. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999; 341: 468-75
6. Ippoliti F, De Santis W, Volterrani A, Lenti L, Canitano N, Lucarelli S, Frediani T. Immuno-modulation during sublingual therapy in allergic children. Pediatr Allergy Immunol 2003; 14: 216-21
7. Khinchi MS, Poulsen LK, Carat F, Andre C, Hansen AB, Malling HJ. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study. Allergy 2004; 59: 45-53
8. La Rosa M, Ranno C, Andre C, Carat F, Tosca MA, Canonica GW. Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 1999; 104: 425-32
9. Lüderitz-Püchel U, Keller-Stanislawski B, Haustein D. Neubewertung des Risikos von Test- und Therapieallergenen. Eine Analyse der UAW-Meldungen von 1991 bis 2000. Bundesgesundheitsbl-Gesundheitsforsch- Gesundheitsschutz 2001; 44: 709-18
10. Malling HJ. Is sublingual immunotherapy clinically effective? Curr Opin Allergy Clin Immunol 2002; 2: 523-31
11. Malling HJ. Criteria for clinical efficacy-readout and monitoring of clinical studies. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 2003; 119-23; discussion 123-5
12. Pajno GB, Vita D, Parmiani S, Caminiti L, La Grutta S, Barberio G. Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate. Clin Exp Allergy 2003; 33: 1641-7
13. Rolinck-Werninghaus C, Wolf H, Liebke C, Baars JC, Lange J, Kopp MV, Hammermann J, Leupold W, Bartels P, Gruebt A, Bauer CP, Schnitker J, Wahn U, Niggemann B. A prospective, randomised, double-blind, placebo-controlled multicentre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy 2004; in press
14. Wilson DR, Torres LI, Durham SR. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2003: CD002893